Hologic (HOLX) Competitors $67.76 -0.86 (-1.25%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$67.21 -0.55 (-0.81%) As of 10/10/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. DXCM, HQY, HSIC, MASI, MMSI, ALC, AMN, AVNS, PEN, and ZBHShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Masimo (MASI), Merit Medical Systems (MMSI), Alcon (ALC), AMN Healthcare Services (AMN), AVANOS MEDICAL (AVNS), Penumbra (PEN), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector. Hologic vs. Its Competitors DexCom HealthEquity Henry Schein Masimo Merit Medical Systems Alcon AMN Healthcare Services AVANOS MEDICAL Penumbra Zimmer Biomet DexCom (NASDAQ:DXCM) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability. Which has more volatility & risk, DXCM or HOLX? DexCom has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Is DXCM or HOLX more profitable? Hologic has a net margin of 13.79% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Hologic's return on equity.Company Net Margins Return on Equity Return on Assets DexCom13.29% 30.41% 10.08% Hologic 13.79%19.69%10.82% Do institutionals & insiders have more ownership in DXCM or HOLX? 97.8% of DexCom shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor DXCM or HOLX? In the previous week, DexCom had 3 more articles in the media than Hologic. MarketBeat recorded 20 mentions for DexCom and 17 mentions for Hologic. DexCom's average media sentiment score of 0.96 beat Hologic's score of 0.92 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 10 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, DXCM or HOLX? Hologic has lower revenue, but higher earnings than DexCom. Hologic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$4.30B5.94$576.20M$1.4445.22Hologic$4.03B3.74$789.50M$2.4128.12 Do analysts prefer DXCM or HOLX? DexCom currently has a consensus price target of $97.42, suggesting a potential upside of 49.60%. Hologic has a consensus price target of $80.15, suggesting a potential upside of 18.29%. Given DexCom's stronger consensus rating and higher probable upside, equities analysts plainly believe DexCom is more favorable than Hologic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 6 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.87Hologic 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.61 SummaryDexCom beats Hologic on 12 of the 17 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.07B$6.82B$6.02B$10.26BDividend YieldN/A1.18%5.67%4.76%P/E Ratio28.1226.2986.0326.56Price / Sales3.74192.56529.47192.49Price / Cash12.3221.4837.2660.57Price / Book3.075.1112.756.52Net Income$789.50M$178.04M$3.31B$276.43M7 Day Performance-0.67%-2.10%0.79%-0.88%1 Month Performance5.14%6.21%6.67%3.48%1 Year Performance-15.10%24.22%77.62%30.15% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.7597 of 5 stars$67.76-1.3%$80.15+18.3%-15.1%$15.07B$4.03B28.127,063Analyst UpgradeDXCMDexCom4.9472 of 5 stars$66.36-1.0%$98.32+48.2%-5.9%$26.02B$4.30B46.0810,300Analyst ForecastHQYHealthEquity4.1878 of 5 stars$87.78-0.9%$119.77+36.4%+6.0%$7.56B$1.20B53.203,120News CoverageAnalyst ForecastInsider TradeHSICHenry Schein3.9512 of 5 stars$66.04-1.5%$76.67+16.1%-10.4%$8.01B$12.67B21.3025,000Analyst ForecastMASIMasimo4.2718 of 5 stars$148.13+0.6%$194.60+31.4%+2.9%$8.05B$2.15B-17.395,600Analyst ForecastMMSIMerit Medical Systems4.68 of 5 stars$83.31-1.1%$107.50+29.0%-16.3%$4.93B$1.43B42.297,400News CoverageAnalyst ForecastALCAlcon3.815 of 5 stars$76.84-0.7%$95.50+24.3%-25.5%$37.90B$10.03B35.7425,599Analyst ForecastAMNAMN Healthcare Services4.5953 of 5 stars$19.83-3.4%$23.25+17.2%-54.2%$759.97M$2.77B-2.552,968News CoverageAnalyst ForecastAVNSAVANOS MEDICAL1.9393 of 5 stars$11.57-1.9%N/A-52.5%$536.85M$687.80M-1.152,227Positive NewsPENPenumbra4.4325 of 5 stars$255.35-0.3%$302.93+18.6%+28.5%$9.96B$1.28B67.914,500Analyst ForecastZBHZimmer Biomet4.8212 of 5 stars$98.88-1.9%$112.44+13.7%-8.4%$19.59B$7.68B24.0617,000Analyst Forecast Related Companies and Tools Related Companies DexCom Alternatives HealthEquity Alternatives Henry Schein Alternatives Masimo Alternatives Merit Medical Systems Alternatives Alcon Alternatives AMN Healthcare Services Alternatives AVANOS MEDICAL Alternatives Penumbra Alternatives Zimmer Biomet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
